Victor Marinescu, MD
Cardiovascular Disease · Naperville, ILNPI 1619130697
Payments from drug & device makers
Across 431 payments — averaging $551.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$193K
- Novartis$21K
- Edwards Lifesciences$15K
- Boston Scientific$2K
- Abbott$1K
- Pfizer$799
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 37 | $192,915 |
| Novartis | 62 | $21,470 |
| Edwards Lifesciences | 49 | $15,482 |
| Boston Scientific | 68 | $2,235 |
| Abbott | 23 | $1,087 |
| Pfizer | 41 | $799 |
| Amgen | 28 | $695 |
| E.r. Squibb & Sons, L.L.C. | 30 | $519 |
| Boehringer Ingelheim | 22 | $458 |
| Sanofi-aventis U.S. LLC | 8 | $256 |
| Abiomed | 2 | $201 |
| Medtronic | 3 | $163 |
| Esperion Therapeutics, Inc. | 3 | $148 |
| Novo Nordisk | 2 | $147 |
| Johnson & Johnson | 7 | $146 |
| AstraZeneca | 7 | $135 |
| Atricure, Inc. | 1 | $98 |
| Scpharmaceuticals Inc. | 4 | $80 |
| Chiesi USA, Inc. | 5 | $77 |
| Alnylam Pharmaceuticals Inc. | 4 | $73 |
| Merck | 4 | $68 |
| Akcea Therapeutics, Inc. | 1 | $52 |
| Lantheus Medical Imaging, Inc. | 3 | $50 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $46 |
| Terumo Medical Corporation | 2 | $44 |
| Cardiva Medical, Inc. | 2 | $43 |
| Regeneron | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Medical Graphics Corporation | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Adagio Medical, Inc. | 1 | $18 |
| Nuwellis, Inc. | 1 | $18 |
| Kestra Medical Technology Services, Inc. | 1 | $14 |
| Elutia, Inc. | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $10 |
How this compares
$237,670 in reported general payments places this provider in the 95th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Naperville
- Alan BrownNaperville$1.5M
- Sujith KalathiveetilNaperville$158K
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Lokesh ChandraHazel Crest$2.7M
- Steven LupovitchArlington Heights$2.6M
- Nitasha SarswatChicago$2M
- Alexander AdlerPeoria$1.5M
- Clifford KavinskyMaywood$1.4M
- Sanjiv ShahChicago$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.